Active, not recruitingNCT05755711

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shockwave Medical, Inc.
Intervention: Shockwave Medical Coronary IVL System(device)
Enrollment: 399 target
Eligibility: 18 years · FEMALE
Timeline: 2023 – 2028

Study locations (30)

Loma Linda University Health, Loma Linda, California, United States
Good Samaritan Hospital, Los Angeles, California, United States
Kaiser Permanente - San Francisco Medical Center, San Francisco, California, United States
Stanford University, Stanford, California, United States
South Denver Cardiology Associates, P.C, Littleton, Colorado, United States
Yale New Haven Hospital, New Haven, Connecticut, United States
Morton Plant Hospital, Clearwater, Florida, United States
Tallahassee Research Institute, Tallahassee, Florida, United States
Emory Hospital, Atlanta, Georgia, United States
Piedmont Heart Institute, Atlanta, Georgia, United States
Northside Hospital, Atlanta, Georgia, United States
Northwestern University, Evanston, Illinois, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Tulane University Center for Clinical Research, New Orleans, Louisiana, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05755711 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials